Location: Sacramento, CA
Chief Executive and Scientific Officer: Steven Watkins
Chief Financial Officer: Brian Sway
Board of Directors: Roger Salquist, Steven Watkins, Anula Jayasuriya, Scott Lenet, Michael Miille

- Lipomics established a leadership position in personalized medicine for metabolic disorders by combining world-class expertise in lipid biology with its technology for quantitative metabolite profiling.

- Lipomics has developed clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation.

- Aquilo ran the sale process and advised Lipomics on structuring a private-to-private acquisition by Tethys Bioscience, a personalized predictive medicine company led by noted biotech executive Mickey Urdea (Chiron and Bayer) and backed by Kleiner Perkins and Mohr Davidow.